Literature DB >> 2185884

Production of endothelin in human cancer cell lines.

M Kusuhara1, K Yamaguchi, K Nagasaki, C Hayashi, A Suzaki, S Hori, S Handa, Y Nakamura, K Abe.   

Abstract

Endothelin (ET)-1 is a vasoconstrictor peptide derived from endothelial cells and now known to be a local regulator of vascular tonus. Recent studies, however, have revealed that ET-1 functions also as growth factor in various cells. By using a specific ET-1 radioimmunoassay, immunoreactive (IR) ET-1, ranging from 4.2 to 150 pM (minimum detectable amount, 4.0 pM), was detected in 13 of 42 human cancer cell lines. The frequencies of IR-ET-1 production and its concentrations were high in mammary, pancreatic, and colon carcinoma cell lines. IR-ET-1 produced by cancer cells possessed the same molecular size as synthetic ET-1 and also had ET-1-like biological activity. Moreover, Northern blot analysis revealed bands corresponding to ET-1 mRNA in cancer cell lines, indicating that IR-ET-1 produced by cancer cells is a product of the ET-1 gene. Since ET-1 in the spent media is present in a sufficient amount to stimulate cellular growth, we sought ET-1 receptors in four pancreatic carcinoma cell lines and human skin fibroblasts. No ET-1 receptors were detected in the pancreatic carcinoma cell lines. However, human skin fibroblasts possessed a large number of ET-1 receptors. This finding raises the possibility that ET-1 produced by cancer cells plays a modulatory role in the growth of stromal cells surrounding cancer cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2185884

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  38 in total

Review 1.  Angiogenesis in cancer: the role of endothelin-1.

Authors:  K Dawas; M Loizidou; A Shankar; H Ali; I Taylor
Journal:  Ann R Coll Surg Engl       Date:  1999-09       Impact factor: 1.891

2.  Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer.

Authors:  Neveen Said; Steven Smith; Marta Sanchez-Carbayo; Dan Theodorescu
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

Review 3.  Endothelin receptor antagonists.

Authors:  Joel B Nelson
Journal:  World J Urol       Date:  2005-01-15       Impact factor: 4.226

4.  Involvement of Endothelin Receptors in Peripheral Sensory Neuropathy Induced by Oxaliplatin in Mice.

Authors:  Renata Bessa Pontes; Mario Roberto Pontes Lisboa; Anamaria Falcão Pereira; Juliana Arcanjo Lino; Francisco Fábio Bezerra de Oliveira; Aline Kelly Viana de Mesquita; Bruno Wesley de Freitas Alves; Roberto César Pereira Lima-Júnior; Mariana Lima Vale
Journal:  Neurotox Res       Date:  2019-06-21       Impact factor: 3.911

5.  Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.

Authors:  Terry W Moody; Irene Ramos-Alvarez; Paula Moreno; Samuel A Mantey; Lisa Ridnour; David Wink; Robert T Jensen
Journal:  Peptides       Date:  2017-01-31       Impact factor: 3.750

Review 6.  Endothelin B receptor, a new target in cancer immune therapy.

Authors:  Lana E Kandalaft; Andrea Facciabene; Ron J Buckanovich; George Coukos
Journal:  Clin Cancer Res       Date:  2009-06-30       Impact factor: 12.531

7.  Increase in immunoreactivity for endothelin-1 in blood vessels of rat liver metastases: experimental sarcoma and carcinoma.

Authors:  A Loesch; M Turmaine; M Loizidou; R Crowe; S Ashraf; I Taylor; G Burnstock
Journal:  J Anat       Date:  1997-08       Impact factor: 2.610

8.  Inhibitory effect of endothelin A receptor blockade on tumor growth and liver metastasis of a human gastric cancer cell line.

Authors:  Rika Fukui; Hidefumi Nishimori; Fumitake Hata; Takahiro Yasoshima; Keisuke Ohno; Yoshiyuki Yanai; Kenjiro Kamiguchi; Ryuichi Denno; Noriyuki Sato; Koichi Hirata
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

9.  The endothelin-integrin axis is involved in macrophage-induced breast cancer cell chemotactic interactions with endothelial cells.

Authors:  Chia-Chi Chen; Li-Li Chen; Yu-Ting Hsu; Ko-Jiunn Liu; Chi-Shuan Fan; Tze-Sing Huang
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

10.  Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor.

Authors:  Bertrand Allard; Anne Wijkhuisen; Aurélie Borrull; Frédérique Deshayes; Fabienne Priam; Patricia Lamourette; Frédéric Ducancel; Didier Boquet; Jean-Yves Couraud
Journal:  MAbs       Date:  2012-12-05       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.